| Dr Julia K Bishop, MD | |
|
717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022-3917 | |
| (402) 815-1700 | |
| (402) 815-1959 |
| Full Name | Dr Julia K Bishop |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 717 N 190th Plz, Elkhorn, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215040126 | NPI | - | NPPES |
| 47068731799 | Medicaid | NE | |
| 10026301600 | Medicaid | NE | |
| 1215040126 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 23141 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
Discovery Laboratories, Inc. announced today that, on June 29, 2015, the Company received a letter from The Nasdaq Stock Market indicating that, because the Company's common stock has not maintained a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, the Company is no longer in compliance with Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
ProtoKinetix, is pleased to announce, that it has entered into a Joint Venture Agreement with Imaginative Research Associates, Inc. to formulate a topical anti-inflammation product for the skin care market.
Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments, according to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics , the official journal of the American Society for Radiation Oncology (ASTRO).
Electroconvulsive therapy (ECT) is considered the most effective treatment option for patients with severe depression who cannot find symptom relief through antidepressant medications or psychotherapy. In a new study, researchers at Butler Hospital and Bradley Hospital in Rhode Island found a sharp decline in the availability and use of ECT in general hospitals across the U.S.
› Verified 3 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
Discovery Laboratories, Inc. announced today that, on June 29, 2015, the Company received a letter from The Nasdaq Stock Market indicating that, because the Company's common stock has not maintained a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, the Company is no longer in compliance with Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
ProtoKinetix, is pleased to announce, that it has entered into a Joint Venture Agreement with Imaginative Research Associates, Inc. to formulate a topical anti-inflammation product for the skin care market.
Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments, according to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics , the official journal of the American Society for Radiation Oncology (ASTRO).
Electroconvulsive therapy (ECT) is considered the most effective treatment option for patients with severe depression who cannot find symptom relief through antidepressant medications or psychotherapy. In a new study, researchers at Butler Hospital and Bradley Hospital in Rhode Island found a sharp decline in the availability and use of ECT in general hospitals across the U.S.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julia K Bishop, MD Po Box 3755, Omaha, NE 68103-0755 Ph: (402) 354-2100 | Dr Julia K Bishop, MD 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022-3917 Ph: (402) 815-1700 |
News Archive
Discovery Laboratories, Inc. announced today that, on June 29, 2015, the Company received a letter from The Nasdaq Stock Market indicating that, because the Company's common stock has not maintained a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, the Company is no longer in compliance with Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.
ProtoKinetix, is pleased to announce, that it has entered into a Joint Venture Agreement with Imaginative Research Associates, Inc. to formulate a topical anti-inflammation product for the skin care market.
Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments, according to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics , the official journal of the American Society for Radiation Oncology (ASTRO).
Electroconvulsive therapy (ECT) is considered the most effective treatment option for patients with severe depression who cannot find symptom relief through antidepressant medications or psychotherapy. In a new study, researchers at Butler Hospital and Bradley Hospital in Rhode Island found a sharp decline in the availability and use of ECT in general hospitals across the U.S.
› Verified 3 days ago
Judith Ann Scott, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. #1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Annamaria Nagy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Dr. Kristen L Hoffman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Neil A Hamill, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 No. 190th Plaza, Suite 2400, Elkhorn, NE 68022 Phone: 402-815-1970 Fax: 402-815-1595 | |
Mark D. Carlson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. # 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Allison H. Phillips, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 |